Sei Investments Co. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.0% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 453,885 shares of the medical equipment provider's stock after buying an additional 4,650 shares during the quarter. Intuitive Surgical comprises 2.2% of Sei Investments Co.'s portfolio, making the stock its 5th biggest holding. Sei Investments Co. owned 0.13% of Intuitive Surgical worth $234,682,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently made changes to their positions in ISRG. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares during the period. Bank Pictet & Cie Europe AG raised its stake in shares of Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares during the period. Mariner LLC grew its position in shares of Intuitive Surgical by 5.1% during the fourth quarter. Mariner LLC now owns 89,122 shares of the medical equipment provider's stock worth $46,520,000 after purchasing an additional 4,327 shares in the last quarter. Evergreen Capital Management LLC grew its position in shares of Intuitive Surgical by 2.7% during the fourth quarter. Evergreen Capital Management LLC now owns 4,268 shares of the medical equipment provider's stock worth $2,228,000 after purchasing an additional 112 shares in the last quarter. Finally, Main Street Financial Solutions LLC grew its position in shares of Intuitive Surgical by 82.0% during the fourth quarter. Main Street Financial Solutions LLC now owns 2,808 shares of the medical equipment provider's stock worth $1,466,000 after purchasing an additional 1,265 shares in the last quarter. Institutional investors own 83.64% of the company's stock.
Wall Street Analyst Weigh In
Several analysts recently issued reports on the company. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wells Fargo & Company increased their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Royal Bank Of Canada increased their target price on Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 23rd. Wall Street Zen upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Finally, Truist Financial increased their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $595.95.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Stock Up 0.7%
NASDAQ ISRG traded up $3.18 during trading on Friday, hitting $480.26. 1,436,064 shares of the stock traded hands, compared to its average volume of 2,192,612. The company has a market capitalization of $172.16 billion, a P/E ratio of 66.98, a price-to-earnings-growth ratio of 5.03 and a beta of 1.59. The firm has a 50-day simple moving average of $508.75 and a 200-day simple moving average of $525.16. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company's quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.78 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.
Insider Transactions at Intuitive Surgical
In other news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,839 shares of company stock worth $7,896,972. 0.70% of the stock is currently owned by company insiders.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.